Will Hughes1, Richard Goodall2, Justin D Salciccioli3, Dominic C Marshall4, Alun H Davies5, Joseph Shalhoub5. 1. Department of Surgery, Broomfield Hospital, Chelmsford, UK. Electronic address: w.hughes1@nhs.net. 2. Academic Section of Vascular Surgery, Department of Surgery & Cancer, Imperial College London, UK. 3. Academic Section of Vascular Surgery, Department of Surgery & Cancer, Imperial College London, UK; Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA, USA. 4. Critical Care Research Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK. 5. Academic Section of Vascular Surgery, Department of Surgery & Cancer, Imperial College London, UK; Department of Vascular Surgery, Imperial College Healthcare NHS Trust, London, UK.
Abstract
OBJECTIVE: Lower extremity amputation (LEA) carries significant mortality, morbidity, and health economic burden. In the Western world, it most commonly results from complications of peripheral arterial occlusive disease (PAOD) or diabetic foot disease. The incidence of PAOD has declined in Europe, the United States, and parts of Australasia. The present study aimed to assess trends in LEA incidence in European Union (EU15+) countries for the years 1990-2017. METHODS: This was an observational study using data obtained from the 2017 Global Burden of Disease (GBD) Study. Age standardised incidence rates (ASIRs) for LEA (stratified into toe amputation, and LEA proximal to toes) were extracted from the GBD Results Tool (http://ghdx.healthdata.org/gbd-results-tool) for EU15+ countries for each of the years 1990-2017. Trends were analysed using Joinpoint regression analysis. RESULTS: Between 1990 and 2017, variable trends in the incidence of LEA were observed in EU15+ countries. For LEAs proximal to toes, increasing trends were observed in six of 19 countries and decreasing trends in nine of 19 countries, with four countries showing varying trends between sexes. For toe amputation, increasing trends were observed in eight of 19 countries and decreasing trends in eight of 19 countries for both sexes, with three countries showing varying trends between sexes. Australia had the highest ASIRs for both sexes in all LEAs at all time points, with steadily increasing trends. The USA observed the greatest reduction in all LEAs in both sexes over the time period analysed (LEAs proximal to toes: female patients -22.93%, male patients -29.76%; toe amputation: female patients -29.93%, male patients -32.67%). The greatest overall increase in incidence was observed in Australia. CONCLUSION: Variable trends in LEA incidence were observed across EU15+ countries. These trends do not reflect previously observed reductions in incidence of PAOD over the same time period.
OBJECTIVE: Lower extremity amputation (LEA) carries significant mortality, morbidity, and health economic burden. In the Western world, it most commonly results from complications of peripheral arterial occlusive disease (PAOD) or diabetic foot disease. The incidence of PAOD has declined in Europe, the United States, and parts of Australasia. The present study aimed to assess trends in LEA incidence in European Union (EU15+) countries for the years 1990-2017. METHODS: This was an observational study using data obtained from the 2017 Global Burden of Disease (GBD) Study. Age standardised incidence rates (ASIRs) for LEA (stratified into toe amputation, and LEA proximal to toes) were extracted from the GBD Results Tool (http://ghdx.healthdata.org/gbd-results-tool) for EU15+ countries for each of the years 1990-2017. Trends were analysed using Joinpoint regression analysis. RESULTS: Between 1990 and 2017, variable trends in the incidence of LEA were observed in EU15+ countries. For LEAs proximal to toes, increasing trends were observed in six of 19 countries and decreasing trends in nine of 19 countries, with four countries showing varying trends between sexes. For toe amputation, increasing trends were observed in eight of 19 countries and decreasing trends in eight of 19 countries for both sexes, with three countries showing varying trends between sexes. Australia had the highest ASIRs for both sexes in all LEAs at all time points, with steadily increasing trends. The USA observed the greatest reduction in all LEAs in both sexes over the time period analysed (LEAs proximal to toes: female patients -22.93%, male patients -29.76%; toe amputation: female patients -29.93%, male patients -32.67%). The greatest overall increase in incidence was observed in Australia. CONCLUSION: Variable trends in LEA incidence were observed across EU15+ countries. These trends do not reflect previously observed reductions in incidence of PAOD over the same time period.
Authors: James Schuster-Bruce; Chinmay Jani; Richard Goodall; Dae Kim; William Hughes; Justin D Salciccioli; Dominic Marshall; Joseph Shalhoub Journal: JAMA Otolaryngol Head Neck Surg Date: 2022-04-01 Impact factor: 8.961
Authors: Richard Goodall; Alexander Armstrong; William Hughes; Charles A Fries; Dominic Marshall; Eleanor B Harbinson; Justin Salciccioli; Joseph Shalhoub Journal: Plast Reconstr Surg Glob Open Date: 2020-11-23
Authors: Dominic C Marshall; Omar Al Omari; Richard Goodall; Joseph Shalhoub; Ian M Adcock; Kian Fan Chung; Justin D Salciccioli Journal: BMC Pulm Med Date: 2022-07-28 Impact factor: 3.320
Authors: Fábio C Lucas de Oliveira; Samuel Williamson; Clare L Ardern; Neil Heron; Dina Christa Janse van Rensburg; Marleen G T Jansen; Sean O'Connor; Linda Schoonmade; Jane Thornton; Babette M Pluim Journal: Sports Med Health Sci Date: 2021-11-12
Authors: Jong Hu Jeon; Hee Seung Yang; Pyoung-Hwa Choi; Eui Jin Ahn; Woo Sob Sim; Dong Young Ahn; Jin Yang Kim; Seul Bin Na Lee; Min Jo; Min Hee Cho Journal: Int J Environ Res Public Health Date: 2022-07-06 Impact factor: 4.614
Authors: Richard Goodall; Andrew Alazawi; Will Hughes; Vassiliki Bravis; Justin D Salciccioli; Dominic C Marshall; Conor Crowley; Joseph Shalhoub Journal: Sci Rep Date: 2021-07-28 Impact factor: 4.996
Authors: Magdalena Walicka; Marta Raczyńska; Karolina Marcinkowska; Iga Lisicka; Arthur Czaicki; Waldemar Wierzba; Edward Franek Journal: J Diabetes Res Date: 2021-07-24 Impact factor: 4.011